BCM
CLS icon

Bayesian Capital Management’s Celestica CLS Stock Holding History

Bayesian Capital Management’s Portfolio CLS Stock Details CLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-965
Closed -$238K – 197
2025
Q3 		$238K Sell
965
-1,235
-56% -$249K 0.05% 427
2025
Q2 		$343K Sell
2,200
-1,457
-40% -$155K 0.05% 367
2025
Q1 		$288K Buy
+3,657
New +$388K 0.05% 400
2024
Q2 		– Sell
-36,926
Closed -$1.66M – 793
2024
Q1 		$1.66M Buy
+36,926
New +$1.4M 0.16% 183
2023
Q1 		– Sell
-12,859
Closed -$145K – 826
2022
Q4 		$145K Buy
+12,859
New +$135K 0.02% 636
2017
Q1 		– Sell
-11,019
Closed -$131K – 443
2016
Q4 		$131K Buy
+11,019
New +$129K 0.03% 554
2016
Q3 		– Sell
-16,793
Closed -$156K – 371
2016
Q2 		$156K Buy
+16,793
New +$175K 0.09% 343

Other funds holding CLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bayesian Capital Management's CLS Position: Q4 2025 in Review

Bayesian Capital Management sold out of Celestica (CLS) in Q4 2025, closing a stake of 965 shares — an estimated $238K sold.

Bayesian Capital Management first reported a position in CLS in Q2 2016 and held it in 7 quarters. The position peaked at $1.66M in Q1 2024. 808 funds tracked by Wall St. Rank hold CLS as of Q4 2025.

  • Bayesian Capital Management reported no remaining Celestica position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 965 Celestica shares in Q4 2025, an estimated $238K.
  • Bayesian Capital Management first reported a position in Celestica in Q2 2016 and held it in 7 quarters.
  • Bayesian Capital Management's Celestica position peaked at $1.66M in Q1 2024.
  • 808 funds tracked by Wall St. Rank held Celestica as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.